Found: 15
Select item for more details and to access through your institution.
DNA methylation signatures of breast cancer in peripheral T-cells.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 2, p. 155, doi. 10.1007/s10637-006-9002-y
- By:
- Publication type:
- Article
Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5′-DFUR, the bioactive metabolite of Xeloda.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 1, p. 217, doi. 10.1007/s10549-011-1756-z
- By:
- Publication type:
- Article
Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-71236-y
- By:
- Publication type:
- Article
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
- Published in:
- Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00024
- By:
- Publication type:
- Article
Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma.
- Published in:
- 2015
- By:
- Publication type:
- Abstract
Characterization of Alistipes montrealensis sp. nov., Isolated from Human Feces of a Patient with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Microbiology Research, 2022, v. 13, n. 1, p. 140, doi. 10.3390/microbiolres13010012
- By:
- Publication type:
- Article
Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-05922-2
- By:
- Publication type:
- Article
Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec.
- Published in:
- Oncologist, 2022, v. 27, n. 10, p. 822, doi. 10.1093/oncolo/oyac123
- By:
- Publication type:
- Article
Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec.
- Published in:
- Oncologist, 2022, v. 27, n. 9, p. 822, doi. 10.1093/oncolo/oyac123
- By:
- Publication type:
- Article
The Mutational Spectrum of Pre- and Post-Neoadjuvant Chemotherapy Triple-Negative Breast Cancers.
- Published in:
- Genes, 2024, v. 15, n. 1, p. 27, doi. 10.3390/genes15010027
- By:
- Publication type:
- Article
Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 911, doi. 10.2147/OTT.S71089
- By:
- Publication type:
- Article
Parathyroid Hormone‐Related Protein Inhibition Blocks Triple‐Negative Breast Cancer Expansion in Bone Through Epithelial to Mesenchymal Transition Reversal.
- Published in:
- JBMR Plus, 2022, v. 6, n. 6, p. 1, doi. 10.1002/jbm4.10587
- By:
- Publication type:
- Article
Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01361
- By:
- Publication type:
- Article